CY5.5 carboxylic acid
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555682

CAS#: 1144107-80-1

Description: CY5.5 carboxylic acid, also known as Cyanine5.5 carboxylic acid, is a Far-red emitting fluorescent dye with Ex/Em wavelength 673nm/707nm. CY5.5 carboxylic acid can be considered non-reactive for most applications and used as a control or reference sample, and for instrument calibration.

Chemical Structure

img
CY5.5 carboxylic acid
CAS# 1144107-80-1
Instruction

Theoretical Analysis

MedKoo Cat#: 555682
Name: CY5.5 carboxylic acid
CAS#: 1144107-80-1
Chemical Formula: C40H42N2O2
Exact Mass: 582.32
Molecular Weight: 582.788
Elemental Analysis: C, 82.44; H, 7.26; N, 4.81; O, 5.49

Price and Availability

Size Price Availability Quantity
5mg USD 450 2 Weeks
25mg USD 750
Bulk inquiry

Synonym: CY5.5-COOH; CY5.5 carboxylic acid; Cyanine5.5 carboxylic acid

IUPAC/Chemical Name: 1H-Benz[e]indolium, 2-[5-[3-(5-carboxypentyl)-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]-1,3-pentadien-1-yl]-1,1,3-trimethyl-, inner salt

InChi Key: MQFHWNVLHOOSOL-UHFFFAOYSA-N

InChi Code: InChI=1S/C40H42N2O2/c1-39(2)34(41(5)32-25-23-28-16-11-13-18-30(28)37(32)39)20-8-6-9-21-35-40(3,4)38-31-19-14-12-17-29(31)24-26-33(38)42(35)27-15-7-10-22-36(43)44/h6,8-9,11-14,16-21,23-26H,7,10,15,22,27H2,1-5H3

SMILES Code: C[N+]1=C(/C=C/C=C/C=C2N(CCCCCC([O-])=O)C3=C(C4=CC=CC=C4C=C3)C/2(C)C)C(C)(C)C5=C1C=CC6=CC=CC=C56

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 582.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Jiang W, Fang H, Liu F, Zhou X, Zhao H, He X, Guo D. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging. Int J Nanomedicine. 2019 Jul 23;14:5611-5622. doi: 10.2147/IJN.S207098. eCollection 2019. PubMed PMID: 31413566; PubMed Central PMCID: PMC6662520.

2: Song D, Yang R, Wang H, Fang S, Liu Y, Long F, Zhu A. Development of dual-color total internal reflection fluorescence biosensor for simultaneous quantitation of two small molecules and their affinity constants with antibodies. Biosens Bioelectron. 2019 Feb 1;126:824-830. doi: 10.1016/j.bios.2018.12.010. Epub 2018 Dec 13. PubMed PMID: 30602264.

3: Stefaniak J, Lewis AM, Conole D, Galan SRG, Bataille CJR, Wynne GM, Castaldi MP, Lundbäck T, Russell AJ, Huber KVM. Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors. ACS Chem Biol. 2018 Oct 19;13(10):2849-2854. doi: 10.1021/acschembio.8b00665. Epub 2018 Sep 19. PubMed PMID: 30216042; PubMed Central PMCID: PMC6198280.

4: Park JH, Cho HJ, Kim DD. Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting. Int J Nanomedicine. 2017 Oct 11;12:7453-7467. doi: 10.2147/IJN.S147668. eCollection 2017. PubMed PMID: 29066894; PubMed Central PMCID: PMC5644567.

5: Ferreira K, Hu HY, Fetz V, Prochnow H, Rais B, Müller PP, Brönstrup M. Multivalent Siderophore-DOTAM Conjugates as Theranostics for Imaging and Treatment of Bacterial Infections. Angew Chem Int Ed Engl. 2017 Jul 3;56(28):8272-8276. doi: 10.1002/anie.201701358. Epub 2017 Jun 13. PubMed PMID: 28608939.

6: Liang X, Fang L, Li X, Zhang X, Wang F. Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy. Biomaterials. 2017 Jul;132:72-84. doi: 10.1016/j.biomaterials.2017.04.006. Epub 2017 Apr 8. PubMed PMID: 28411450.

7: Malinovskaya Y, Melnikov P, Baklaushev V, Gabashvili A, Osipova N, Mantrov S, Ermolenko Y, Maksimenko O, Gorshkova M, Balabanyan V, Kreuter J, Gelperina S. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. Int J Pharm. 2017 May 30;524(1-2):77-90. doi: 10.1016/j.ijpharm.2017.03.049. Epub 2017 Mar 27. PubMed PMID: 28359811.

8: Jung B, Shim MK, Park MJ, Jang EH, Yoon HY, Kim K, Kim JH. Hydrophobically modified polysaccharide-based on polysialic acid nanoparticles as carriers for anticancer drugs. Int J Pharm. 2017 Mar 30;520(1-2):111-118. doi: 10.1016/j.ijpharm.2017.01.055. Epub 2017 Feb 4. PubMed PMID: 28179099.

9: Kang CS, Ren S, Sun X, Chong HS. Theranostic Polyaminocarboxylate-Cyanine-Transferrin Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging. ChemMedChem. 2016 Oct 6;11(19):2188-2193. doi: 10.1002/cmdc.201600072. Epub 2016 Sep 14. PubMed PMID: 27624789; PubMed Central PMCID: PMC5118032.

10: Zhang Y, Guo C, Li S, Luo K, Hu J, Gu Z. The Potential of Poly[N-(2-hydroxypropyl)methacrylamide] via Reversible Addition-Fragmentation Chain Transfer Polymerization as Safe Nanocarrier. J Nanosci Nanotechnol. 2016 Jun;16(6):5746-54. PubMed PMID: 27427626.

11: Su T, Wang Y, Wang J, Han D, Ma S, Cao J, Li X, Zhang R, Qiao H, Liang J, Liu G, Yang B, Liang S, Nie Y, Wu K, Li J, Cao F. In Vivo Magnetic Resonance and Fluorescence Dual-Modality Imaging of Tumor Angiogenesis in Rats Using GEBP11 Peptide Targeted Magnetic Nanoparticles. J Biomed Nanotechnol. 2016 May;12(5):1011-22. PubMed PMID: 27305822.

12: Wang Y, Chen J, Yang B, Qiao H, Gao L, Su T, Ma S, Zhang X, Li X, Liu G, Cao J, Chen X, Chen Y, Cao F. In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles. Theranostics. 2016 Jan 1;6(2):272-86. doi: 10.7150/thno.13350. eCollection 2016. PubMed PMID: 26877785; PubMed Central PMCID: PMC4729775.

13: Lee JY, Chung SJ, Cho HJ, Kim DD. Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging. Biomaterials. 2016 Apr;85:218-31. doi: 10.1016/j.biomaterials.2016.01.060. Epub 2016 Jan 29. PubMed PMID: 26874284.

14: Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Colloids Surf B Biointerfaces. 2016 Feb 1;138:1-9. doi: 10.1016/j.colsurfb.2015.11.033. Epub 2015 Nov 28. PubMed PMID: 26638176.

15: Zhang L, Tian B, Li Y, Lei T, Meng J, Yang L, Zhang Y, Chen F, Zhang H, Xu H, Zhang Y, Tang X. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy. ACS Appl Mater Interfaces. 2015 Nov 18;7(45):25147-61. doi: 10.1021/acsami.5b06488. Epub 2015 Nov 4. PubMed PMID: 26501354.

16: Zhao T, Li Y, Liu B, Pan B, Cheng X, Georgoff P, Alam HB. Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model. J Trauma Acute Care Surg. 2016 Jan;80(1):34-40; discussion 40-1. doi: 10.1097/TA.0000000000000897. PubMed PMID: 26491797; PubMed Central PMCID: PMC4688101.

17: Wilks MQ, Normandin MD, Yuan H, Cho H, Guo Y, Herisson F, Ayata C, Wooten DW, El Fakhri G, Josephson L. Imaging PEG-like nanoprobes in tumor, transient ischemia, and inflammatory disease models. Bioconjug Chem. 2015 Jun 17;26(6):1061-9. doi: 10.1021/acs.bioconjchem.5b00213. Epub 2015 May 14. PubMed PMID: 25971846; PubMed Central PMCID: PMC5378316.

18: Park JH, Lee JY, Termsarasab U, Yoon IS, Ko SH, Shim JS, Cho HJ, Kim DD. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery. Int J Pharm. 2014 Oct 1;473(1-2):426-33. doi: 10.1016/j.ijpharm.2014.07.038. Epub 2014 Jul 28. PubMed PMID: 25079433.

19: Lee CM, Cheong SJ, Kim EM, Lim ST, Jeong YY, Sohn MH, Jeong HJ. Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform. J Nucl Med. 2013 Nov;54(11):1974-80. doi: 10.2967/jnumed.113.122267. Epub 2013 Sep 19. PubMed PMID: 24050935.

20: Clond MA, Lee BS, Yu JJ, Singer MB, Amano T, Lamb AW, Drazin D, Kateb B, Ley EJ, Yu JS. Reactive oxygen species-activated nanoprodrug of Ibuprofen for targeting traumatic brain injury in mice. PLoS One. 2013 Apr 24;8(4):e61819. doi: 10.1371/journal.pone.0061819. Print 2013. PubMed PMID: 23637912; PubMed Central PMCID: PMC3634829.